Bioabsorbable Stents (BAS) – Pipeline Products by Stage of Development 13
Bioabsorbable Stents (BAS) – Pipeline Products by Territory 14
Bioabsorbable Stents (BAS) – Pipeline Products by Regulatory Path 15
Bioabsorbable Stents (BAS) – Pipeline Products by Estimated Approval Date 16
Bioabsorbable Stents (BAS) – Ongoing Clinical Trials 17
Bioabsorbable Stents (BAS) Companies – Pipeline Products by Stage of Development 18
Bioabsorbable Stents (BAS) – Pipeline Products by Stage of Development 20
Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Second Generation Bioresorbable Vascular Scaffold – Product Status 22
Second Generation Bioresorbable Vascular Scaffold – Product Description 22
Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
80-micron MAGNITUDE Bioresorbable Scaffold – Product Status 23
80-micron MAGNITUDE Bioresorbable Scaffold – Product Description 23
APTITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Status 24
APTITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Description 24
DEFIANCE Scaffold – Product Status 24
DEFIANCE Scaffold – Product Description 25
FORTITUDE Scaffold – Product Status 25
FORTITUDE Scaffold – Product Description 25
MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Status 26
MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Description 26
Second Generation FORTITUDE Scaffold – Product Status 26
Second Generation FORTITUDE Scaffold – Product Description 27
Amaranth Medical Inc – Ongoing Clinical Trials Overview 28
FORTITUDE Scaffold – Amaranth Endovascular Study of a Drug-eluting Bioresorbable Coronary Scaffold 29
FORTITUDE Scaffold – Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds – European Trial 29
APTITUDE Sirolimus-Eluting Bioresorbable Scaffold – Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds – Extended Trial II 30
MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold – Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds – Extended Trial III 31
Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
Arteriosorb Absorbable Drug-Eluting Scaffold – Product Status 32
Arteriosorb Absorbable Drug-Eluting Scaffold – Product Description 32
Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Sparrow Drug Eluting Stent System – Product Status 33
Sparrow Drug Eluting Stent System – Product Description 33
Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Biodegradable Endovascular Implant – Product Status 34
Biodegradable Endovascular Implant – Product Description 34
Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 35
DREAMS 3G System – Product Status 35
DREAMS 3G System – Product Description 35
Magmaris Bioresorbable Magnesium Scaffold – Product Status 36
Magmaris Bioresorbable Magnesium Scaffold – Product Description 36
Biotronik AG – Ongoing Clinical Trials Overview 37
Magmaris Bioresorbable Magnesium Scaffold – A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions: The BIFSORB Pilot Study II 38
Magmaris Bioresorbable Magnesium Scaffold – BIOTRONIK – Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-II 38
Magmaris Bioresorbable Magnesium Scaffold – Biotroniks – Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV 38
Magmaris Bioresorbable Magnesium Scaffold – BIOTRONIKS-Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris (BIOSOLVE)-IV Magmaris Swiss Satellite Registry 39
Magmaris Bioresorbable Magnesium Scaffold – Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-segment Elevation Myocardial Infarction (NSTEMI) 39
Magmaris Bioresorbable Magnesium Scaffold – Optical Coherence Guided Treatment of ST-segment Elevation Myocardial Infarction with the Drug-eluting Resorbable Magnesium Scaffold: The BEST- MAG Multicentre Study (Belgian ST-segment Elevation Myocardial Infarction Treatment with Resorbable Magnesium Scaffold) 39
Magmaris Bioresorbable Magnesium Scaffold – Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds Magmaris (MAGIC Registry) 40
Magmaris Bioresorbable Magnesium Scaffold – RMS (Resorbable Magnesium Scaffolds) Registry 40
Magmaris Bioresorbable Magnesium Scaffold – Scaffold Implantation in Emilia-Romagna 40
DREAMS 3G System – BIOTRONIK – Safety and Clinical Performance of the – Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries 41
Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 42
AMS-2 – Product Status 42
AMS-2 – Product Description 42
Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
IBS Angel – Product Status 43
IBS Angel – Product Description 43
Biotyx Medical (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview 44
IBS Angel – A Prospective, Multi-center, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of Iron Bioresorbable Scaffold System (IBS Angel) in Patients with Pulmonary Artery Stenosis 45
Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 46
Fully Resorbable Drug-Eluting Scaffold System – Product Status 46
Fully Resorbable Drug-Eluting Scaffold System – Product Description 46
Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 47
Cardiosorb – Product Status 47
Cardiosorb – Product Description 47
Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 48
SymBio Pimecrolimus/Paclitaxel-Eluting Stent – Product Status 48
SymBio Pimecrolimus/Paclitaxel-Eluting Stent – Product Description 48
HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
Xinsorb BRS – Product Status 49
Xinsorb BRS – Product Description 49
Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Biosorb Pediatric Dissolving Stent – Product Status 50
Biosorb Pediatric Dissolving Stent – Product Description 50
Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
Bioabsorbable Stent – Product Status 51
Bioabsorbable Stent – Product Description 51
Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
Igaki-Tamai Coronary Stent – Product Status 52
Igaki-Tamai Coronary Stent – Product Description 52
Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – Product Status 53
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – Product Description 53
Lifetech Scientific (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview 54
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – A First-in-man Study of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System (IBS) 55
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – A Prospective, Multi-center, Single-arm Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-III 55
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – A Prospective, Multi-center, Single-blinded, Randomized Trial of the Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-II 55
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – A Prospective, Non-randomized, Open-label, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System 56
IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – Feasibility, Efficacy and Safety of IBS for Implantation in the PDA in Duct-dependent Cyanotic CHD 56
Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
Mirage – Product Status 57
Mirage – Product Description 57
Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
MeRes100 – Product Status 58
MeRes100 – Product Description 58
Meriskin BRS – Product Status 59
Meriskin BRS – Product Description 59
Meril Life Sciences Pvt Ltd – Ongoing Clinical Trials Overview 60
MeRes100 – A Multi Center Randomized Control Study of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System in Treatment of Coronary Artery Disease Patients: MeRes – China 61
MeRes100 – A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions: MeRes-1 Extend 61
Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Bioresorbable Scaffold (BRS) – Product Status 62
Bioresorbable Scaffold (BRS) – Product Description 62
Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview 63
Bioabsorbable Stent – Product Status 63
Bioabsorbable Stent – Product Description 63
MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 64
Firefalcon Bioresorbable Device – Product Status 64
Firefalcon Bioresorbable Device – Product Description 64
Firesorb – Product Status 65
Firesorb – Product Description 65
MicroPort Scientific Corp – Ongoing Clinical Trials Overview 66
Firesorb – A First-in-man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: FUTURE-I 67
Firesorb – A Prospective Multicenter Single-arm Clinical Trial Assessing the Safety and Effectiveness of Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold for the Treatment of Coronary Artery Disease: FUTURE III 67
Firesorb – A Randomized Trial of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: FUTURE-II 67
Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview 68
Nile LM SIR Sirolimus Eluting Intracoronary Stent – Product Status 68
Nile LM SIR Sirolimus Eluting Intracoronary Stent – Product Description 68
MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Smart-1 DES – Product Status 69
Smart-1 DES – Product Description 69
Smart-4 DES – Product Status 70
Smart-4 DES – Product Description 70
VESTAsync – Product Status 70
VESTAsync – Product Description 71
NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Nanocoating Cardiac Stent – Product Status 72
Nanocoating Cardiac Stent – Product Description 72
North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 73
Biodegradable Metal Stent – Product Status 73
Biodegradable Metal Stent – Product Description 73
Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 74
Liquid Cast Drug-Eluting Biodegradable Stent – Product Status 74
Liquid Cast Drug-Eluting Biodegradable Stent – Product Description 74
OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 75
Cura Stent – Product Status 75
Cura Stent – Product Description 75
Sirolimus-Eluting Absorbable Vascular Scaffold – Product Status 76
Sirolimus-Eluting Absorbable Vascular Scaffold – Product Description 76
Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview 77
Pediatric Bioresorbable Stent – Product Status 77
Pediatric Bioresorbable Stent – Product Description 77
QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 78
Biodegradable Coronary Stent – Product Status 78
Biodegradable Coronary Stent – Product Description 78
REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Product Status 79
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Product Description 80
REVA Medical Inc – Ongoing Clinical Trials Overview 81
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Expanded FANTOM II Clinical Study 82
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold 82
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Post Market Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold 82
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Safety and Efficacy of the FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo Coronary Artery Disease: The ENCORE-I Study 83
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Safety and Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold 83
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Vascular Healing Pattern, Vasoreactivity, and Quality of Life in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention with Sirolimus Eluting FANTOM Bioresorbable Vascular Scaffold with Long Term Clinical, Near Infrared Spectroscopy and Optical Coherence Tomography Follow-up: A FANTOM STEMI Pilot Study 83
S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 84
3V Avatar – Product Status 84
3V Avatar – Product Description 84
Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
Bioheart BRS System – Product Status 85
Bioheart BRS System – Product Description 85
Bioheart Ultra BRS System – Product Status 86
Bioheart Ultra BRS System – Product Description 86
Shanghai Bio-heart Biological Technology Co Ltd – Ongoing Clinical Trials Overview 87
Bioheart BRS System – A Randomized Controlled Trial of the Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System in Patients With Coronary Artery Disease: BIOHEART-II 88
Bioheart BRS System – A Registry Trial of the Bioheart Rapamycin Drug-eluting Bioresorbable Coronary Stent System in Patients with Coronary Artery Disease: BIOHEART III 88
Bioheart BRS System – Study of Bioheart BRS System for the Treatment of Coronary Artery Disease 88
Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
Biodegradable Sinus Stent – Product Status 89
Biodegradable Sinus Stent – Product Description 89
Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 90
TephaFLEX Absorbable Coronary Stent – Product Status 90
TephaFLEX Absorbable Coronary Stent – Product Description 90
Tremedics Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 91
Illusicor – Product Status 91
Illusicor – Product Description 91
University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview 92
Endothelium Nanomatrix Coated Stent – Product Status 92
Endothelium Nanomatrix Coated Stent – Product Description 92
University of Florida Pipeline Products & Ongoing Clinical Trials Overview 93
Nanocomposite Drug Eluting Stent – Product Status 93
Nanocomposite Drug Eluting Stent – Product Description 93
University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 94
Magnesium Alloy Stent – Product Status 94
Magnesium Alloy Stent – Product Description 94
VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
PowerStent Absorb DES – Product Status 95
PowerStent Absorb DES – Product Description 95
Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview 96
Ideal BioStent – First Generation – Product Status 96
Ideal BioStent – First Generation – Product Description 96
Ideal BioStent – Second Generation – Product Status 97
Ideal BioStent – Second Generation – Product Description 97
Whisper Coronary Stent System – Product Status 97
Whisper Coronary Stent System – Product Description 98
Glossary 110
